Source:http://linkedlifedata.com/resource/pubmed/id/11567218
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-9-21
|
pubmed:abstractText |
To analyze the spontaneous pathologic progression of chronic hepatitis C, we analyzed the histopathologic semiquantitative scores (Metavir and Knodell) of sequential liver biopsies performed in untreated hepatitis C virus (HCV)-infected patients. Subjects included 35 men and 41 women, with a mean age of 41 +/- 12 years, a duration of HCV infection of 11 +/- 5 years, and an interval between liver biopsies of 3.7 +/- 2.5 years. Results obtained using the Knodell score and the Metavir score were similar. At the first biopsy, 78.9% of patients had a low activity score (A0-A1) and 82.9% had a low fibrosis score (F0-F2). At the second biopsy, the activity decreased in 9.2%, was unchanged in 72.4%, and increased in 18.5%. An increase in activity was more frequently observed in patients infected with genotype 1 (28.9%) than with others (7.7%; P =.04); the yearly progression of activity was significantly higher in patients with a low rather than high initial activity score (0.11 v -0.02; P <.01). An increase in fibrosis was noted in 13.3% of those with a low and 43.8% of those with a high initial activity score (P <.01), with a highest rate of yearly fibrosis progression (0.12 U). In multivariate analysis, only a high activity score was significantly associated with an increased risk of fibrosis progression (relative risk, 25.5; 95% confidence interval, 2.7 to 238; P =.004). Spontaneous chronic hepatitis C evolution is worsening in only 20% of patients. Fibrosis progression is significantly associated with the necroinflammatory activity suggesting that this factor should be regarded as a major clue for deciding therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0046-8177
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 by W.B. Saunders Company
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
904-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11567218-Adult,
pubmed-meshheading:11567218-Alanine Transaminase,
pubmed-meshheading:11567218-Antibodies, Viral,
pubmed-meshheading:11567218-Biopsy,
pubmed-meshheading:11567218-Disease Progression,
pubmed-meshheading:11567218-Female,
pubmed-meshheading:11567218-Hepacivirus,
pubmed-meshheading:11567218-Hepatitis C, Chronic,
pubmed-meshheading:11567218-Humans,
pubmed-meshheading:11567218-Liver,
pubmed-meshheading:11567218-Liver Cirrhosis,
pubmed-meshheading:11567218-Male,
pubmed-meshheading:11567218-RNA, Viral
|
pubmed:year |
2001
|
pubmed:articleTitle |
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.
|
pubmed:affiliation |
Unité d'Hépatologie and INSERM U370, Hôpital Necker, Paris, France.
|
pubmed:publicationType |
Journal Article
|